Currently, the consensus recommendations for GH therapy initiation is to start before the onset of obesity, which can often start before 2 years of age, as the greatest benefits are shown when treatment is initiated early in life [17, 38]. This evidence concerns the gene GH1 and obesity due to melanocortin 4 receptor deficiency.